Literature DB >> 12588046

Cardiovascular action of insulin-like growth factor-1 is not mediated by calcitonin gene-related peptide neurons.

Crystal R McRae1, Sumangala P Rao, Joseph C Dunbar.   

Abstract

Calcitonin gene-related peptide (CGRP) is a potent vasodilator located in the peripheral nerves including the perivascular nerves. Previous studies in our laboratory determined that the vasodilatory action of insulin is mediated in part by CGRP-containing neurons. Since insulin-like growth factor-1 (IGF-1) and insulin share molecular and receptor structural similarity as well as functional similarity, we investigated the role of the CGRP-containing neurons in IGF-1-mediated vasodilation. Wistar rats were made CGRP deficient by treatment with capsaicin (50 mg/kg) 1-3 d after birth. Vehicle-treated controls and CGRP-deficient rats were maintained for 12 to 13 wk. At this time rats were fasted overnight, anesthetized with urethane and chloralose, and prepared for cardiovascular recordings. The basal mean arterial pressure (MAP) was higher in CGRP-deficient rats when compared with controls. The infusion of IGF-1 resulted in an equivalent decrease in MAP in both the CGRP-deficient and control rats. IGF-1 infusion did not change the heart rate in control rats but decreased it in CGRP-deficient rats. IGF-1 also increased flow as determined by conductance in the iliac, renal, and superior mesenteric vascular beds in both vehicle controls and CGRP-deficient rats. We concluded that unlike insulin the IGF-1-mediated vasodilatory response is not mediated by the CGRP-dependent perivascular neurons.

Entities:  

Mesh:

Substances:

Year:  2002        PMID: 12588046     DOI: 10.1385/ENDO:19:2:163

Source DB:  PubMed          Journal:  Endocrine        ISSN: 1355-008X            Impact factor:   3.633


  26 in total

1.  Positive inotropic effects of CGRP and isoprenaline: analogies and differences.

Authors:  L Mantelli; S Amerini; S Filippi; F Ledda
Journal:  Neuropeptides       Date:  1992-11       Impact factor: 3.286

2.  Insulin-like growth factor-I decreases mean blood pressure and selectively increases regional blood flow in normal rats.

Authors:  G Pete; Y Hu; M Walsh; J Sowers; J C Dunbar
Journal:  Proc Soc Exp Biol Med       Date:  1996-11

3.  Insulin-like growth factor-I decreases sympathetic nerve activity: the effect is modulated by glycemic status.

Authors:  Z Duanmu; K Lapanowski; J C Dunbar
Journal:  Proc Soc Exp Biol Med       Date:  1997-10

4.  Mechanisms mediating insulin-induced hypotension in rats. A role for nitric oxide and autonomic mediators.

Authors:  J C Dunbar; D S O'Leary; G Wang; J Wright-Richey
Journal:  Acta Diabetol       Date:  1996-12       Impact factor: 4.280

5.  Effects of general and selective beta-adrenergic antagonists on insulin-induced cardiac and selected vascular responses in rats.

Authors:  C M Hauck; J C Dunbar
Journal:  Acta Diabetol       Date:  1999-06       Impact factor: 4.280

6.  Insulin like growth factor 1 increases vascular smooth muscle nitric oxide production.

Authors:  R Muniyappa; M F Walsh; J S Rangi; R M Zayas; P R Standley; J L Ram; J R Sowers
Journal:  Life Sci       Date:  1997       Impact factor: 5.037

7.  Regional blood flow dynamics in response to insulin and IGF-1 in diabetic animals.

Authors:  G Pete; J C Dunbar
Journal:  Clin Exp Hypertens       Date:  1998-01       Impact factor: 1.749

8.  The insulin-mediated vascular and blood pressure responses are suppressed in CGRP-deficient normal and diabetic rats.

Authors:  Nahla Salem; Joseph C Dunbar
Journal:  Diabetes Metab Res Rev       Date:  2002 May-Jun       Impact factor: 4.876

9.  Human alpha-calcitonin gene-related peptide stimulates adenylate cyclase and guanylate cyclase and relaxes rat thoracic aorta by releasing nitric oxide.

Authors:  D W Gray; I Marshall
Journal:  Br J Pharmacol       Date:  1992-11       Impact factor: 8.739

10.  Insulin-like growth factor I diminishes in vivo and in vitro vascular contractility: role of vascular nitric oxide.

Authors:  M F Walsh; M Barazi; G Pete; R Muniyappa; J C Dunbar; J R Sowers
Journal:  Endocrinology       Date:  1996-05       Impact factor: 4.736

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.